Squarepoint Ops LLC cut its position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Free Report) by 64.3% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 44,205 shares of the company's stock after selling 79,691